Global Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market, By Active Ingredients (Delafloxacin, Vancomycin, Ceftaroline Fosamil, Linezolid, Others), Route of Administration (Parental, Oral, Tropical), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market Analysis and Size
The complicated global skin and skin structure infections (cSSSI) drugs market are expected to witness significant growth during the forecast period. The most common way of getting skin infections is via viral skin infection, bacterial infection, and fungal infection. These are the primary factors driving the drug market growth for complicated skin and skin structure infections. Furthermore, parasitic skin infections involving organisms burrowing below the skin will increase the occurrences of skin infection malformations. This factor will increase the growth of the complicated skin and skin structure infections (cSSSI) drugs market growth.
Data Bridge Market Research analyses a growth rate in the complicated global skin and skin structure infections (cSSSI) drugs market in the forecast period 2023-2030. The expected CAGR of the complicated global skin and skin structure infections (cSSSI) drugs market is around 10.00% in the forecast period. The market was valued at USD 8.7 billion in 2022, and it would grow to USD 18.65 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Active Ingredients (Delafloxacin, Vancomycin, Ceftaroline Fosamil, Linezolid, Others), Route of Administration (Parental, Oral, Tropical),End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Novartis AG (Switzerland), Endo International Inc. (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Cipla Inc (India), Dr Reddy's Laboratories Ltd (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), Zydus Group (India), Lupin (India), Melinta Therapeutics, Inc (U.S.), MerLion Pharmaceuticals GmbH (Germany), Paratek Pharmaceuticals, Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Skin and skin structure infections are among the most common bacterial infection of skin-related tissues. The increased antimicrobial resistance among both gram-positive and gram-negative bacteria is a rapidly growing reason for hospitalization in complicated skin structural infections. Skin structural infections are usually considered complicated in case of needed surgery combined with antimicrobial therapy. The complicated skin structural infections generally include burns, ulcers, and major underlying diseases that complicate antibiotic treatment. The major symptoms of skin and skin structure infections include pus, blisters, skin sloughing, breakdown, and skin being discolored and painful.
Global Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market Dynamics
Drivers
- Increase in Skin Infections
The occurrence of skin infections has been witnessed worldwide, such as pyoderma (prevalence range 0.2-35%, tinea capitis (1-19.7%), scabies (0.2-24%, 1.3-17% in Sub-Saharan Africa), 6.9-35% in Sub-Saharan Africa), viral skin disorders (0.4-9%, mostly molluscum contagiosum), pediculosis capitis (0-57%). This boosts the growth of the market.
- Rising Demand for Oral Drugs
Oral drugs are expected to boost market growth. The segment is projected to speed up the global market as many of the products are accessible in capsule and tablet form, and it is a very convenient route of administration.
Opportunities
- Increasing Drug Developments
The increasing developments associated with the market are expected to create many opportunities for market growth. For instance, the recent developments of the drug named dalbavancin used for treating acute bacterial infection by a key market player called duratra therapeutics, will also help in evolving the growth of the complicated global skin and skin structure infections (cSSSI) drugs market.
- Increasing Demand for Retail Pharmacies
The rise in the number of cSSSI therapeutics delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for market growth. Additionally, patients choose retail pharmacies for purchasing drugs, as these are easily available.
Restraints/Challenges
- Limited Studies and Surveys
There are very limited studies and surveys that are hindering the growth of the market. Only a small amount of data are available concerning the clinical and research studies. A few studies mainly focused on groups from a single hospital where only a limited number of patients were observed. Thus, this hampers the growth of the market.
- High Cost
The huge expenditure associated with complicated skin and skin structure infections medications hampers the market growth. This disease involves treatment with corticosteroids, and different immunosuppressive agents, which demands huge expenditure. This acts as a major limitation for the market.
This complicated global skin and skin structure infections (cSSSI) drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global complicated skin and skin structure infections (cSSSI) drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market Scope
The global complicated skin and skin structure infections (cSSSI) drugs market is segmented on the basis of active ingredients, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Active Ingredients
- Delafloxacin
- Vancomycin
- Ceftaroline Fosamil
- Linezolid
- Others
Route of Administration
- Oral
- Topical
- Parenteral
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market Regional Analysis/Insights
The global complicated skin and skin structure infections (cSSSI) drugs market is analysed and market size insights and trends are provided by active ingredients, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global complicated skin and skin structure infections (cSSSI) drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for the complicated global skin and skin structure infections (cSSSI) drugs market throughout the forecasted period due to the presence of key manufacturers of the product, increasing research and development activities, healthcare expenditure, and skilled professionals in the region
Asia-Pacific dominates the market due to increased new research and developments on skin infections medications and the growth and expansion of healthcare infrastructure in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market Share Analysis
The global complicated skin and skin structure infections (cSSSI) drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global complicated skin and skin structure infections (cSSSI) drugs market
Key players operating in the global complicated skin and skin structure infections (cSSSI) drugs market include:
- Novartis AG (Switzerland)
- Endo International Inc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Glenmark Pharmaceuticals Ltd (India)
- Cipla Inc (India)
- Dr Reddy's Laboratories Ltd (India)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Pfizer Inc (U.S.)
- Zydus Group (India)
- Lupin (India)
- Melinta Therapeutics, Inc (U.S.)
- MerLion Pharmaceuticals GmbH (Germany)
- Paratek Pharmaceuticals, Inc (U.S.)
Research Methodology: Global Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
SKU-